$LGVN Balance Sheet | Understand Stock

$LGVN

$1.75 -$0.03 (1.69%) Close

$LGVN Overview Financial Statements SEC Filings Executives News Red Flags Capital Raising Ownership Insider Transactions Congressional Trades

Financial Statements

Income Statement Balance Sheet Cashflow Statement

Balance Sheets

In millions of USD, except per-share amounts

	Q2 FY2026 As of Jun 30, 2026	Q1 FY2026 As of Mar 31, 2026	Q4 FY2025 As of Dec 31, 2025	Q3 FY2025 As of Sep 30, 2025	Q2 FY2025 As of Jun 30, 2025	Q1 FY2025 As of Mar 31, 2025	Q4 FY2024 As of Dec 31, 2024	Q3 FY2024 As of Sep 30, 2024	Q2 FY2024 As of Jun 30, 2024	Q1 FY2024 As of Mar 31, 2024	Q4 FY2023 As of Dec 31, 2023	Q3 FY2023 As of Sep 30, 2023	Q2 FY2023 As of Jun 30, 2023	Q1 FY2023 As of Mar 31, 2023	Q4 FY2022 As of Dec 31, 2022	Q3 FY2022 As of Sep 30, 2022	Q2 FY2022 As of Jun 30, 2022	Q1 FY2022 As of Mar 31, 2022	Q4 FY2021 As of Dec 31, 2021	Q3 FY2021 As of Sep 30, 2021
Current assets:
Short-term investments at fair value (cost of $9,063 and $9,471 at September 30, 2022, and December 31, 2021, respectively)
Cash and cash equivalents
Short-term investments
Marketable securities
Marketable equity securities
Prepaid expenses and other current assets
Accounts receivable
Total current assets

Property and equipment, net
Intangible assets, net
Right-of-use (ROU) asset
Operating lease asset, net
Other assets
Total assets
Current liabilities:
Accounts payable
Accrued expenses
Current portion of lease liability
Estimated lawsuit liability
Deferred revenue
Other current liabilities
Total current liabilities
Long-term liabilities:

Lease liability
Lease liability
Total long-term liabilities
Long-term liabilities:
Long-term portion of operating lease liability
Liability related to the sale of future PRV proceeds
Other liabilities
Total long-term liabilities
Total liabilities
Stockholders’ equity:
Common stock value
Class A Common Stock
Class B Common Stock
Total common stock value

Class B Common Stock, $0.001 par value per share, 15,705,000 shares authorized, 14,855,539 shares issued and outstanding at June 30, 2023; 14,891,085 issued and outstanding, at December 31, 2022
Additional paid-in capital
Stock subscription receivable
Accumulated deficit
Accumulated other comprehensive loss
Total stockholders’ equity

Total liabilities and stockholders’ equity

Comments